Medical Therapy versus Sinus Surgery by Using Balloon Sinus Dilation Technology: A Prospective Multicenter Study

Author:

Payne Spencer C.1,Stolovitzky Pablo2,Mehendale Neelesh3,Matheny Keith4,Brown William5,Rieder Anthony6,Liepert Douglas7,Tseng Ewen4,Gould Andrew8,Powell Scott9,Van Himbergen Daniel10,Karanfilov Boris11,Harfe Daniel12,England Laura12,Melroy Christopher13

Affiliation:

1. Department of Otolaryngology - Head & Neck Surgery, University of Virginia, Charlottesville, Virginia

2. ENT of Georgia, Atlanta, Georgia

3. ENT Associates of Texas, McKinney, Texas

4. Collin County ENT, Frisco, Texas

5. South Florida ENT Associates, Miami, Florida

6. Alliance ENT and Hearing Center, Wauwatosa, Wisconsin

7. Allied ENT Specialty Center South Bend, Indiana

8. Advanced ENT and Allergy, Louisville, Kentucky

9. Florida E.N.T. & Allergy, Tampa, Florida

10. Virginia Ear Nose and Throat, Henrico, Virginia

11. Ohio Sinus Institute, Dublin, Ohio

12. Acclarent, Inc., Menlo Park, California

13. Georgia Nasal and Sinus Institute, Savannah, Georgia

Abstract

Background Although previous studies of sinus surgery that used balloon catheter dilation technology for the paranasal sinuses (balloon sinus dilation [BSD]) demonstrated safety and efficacy, data that compare BSD with continued medical management (MM) are lacking. Objective To evaluate the outcomes of sinus surgery when using BSD instruments versus MM for patients with chronic rhinosinusitis for whom MM failed. Methods Adult patients with chronic rhinosinusitis for whom a minimum of 3 weeks of oral antibiotics, 4 weeks of daily saline solution therapy, and 4 weeks of daily nasal corticosteroids failed were included. Qualifying participants were allowed to self-select sinus surgery with BSD (either an office or operating room setting) or continued MM. The primary end point was the comparison of change in the Chronic Sinusitis Survey score from baseline to 24 weeks. Secondary end points included comparisons of change for the Rhinosinusitis Disability Index (RSDI) and the Sino-Nasal Outcome Test (SNOT-20). Results A total of 198 patients were enrolled (146 surgery and 52 MM). Of the patients who chose BSD, 72% (105/146) had their procedures completed in an office setting. Overall, BSD instruments were successful in dilating 97.6% of targeted sinuses (561/575). Patients who chose BSD showed a significantly greater improvement in the Chronic Sinusitis Survey score versus MM (42.0 versus 27.0, p < 0.001). Results from the RSDI and SNOT-20 surveys showed similar improvements for surgery versus MM (RSDI, 36.0 versus 18.1, p < 0.001; SNOT-20, 1.7 versus 1.0, p < 0.002). Conclusion Patients who selected sinus surgery in which BSD instruments were used on the peripheral sinuses demonstrated significantly greater improvements in quality of life compared with those who elected ongoing MM. These results were achieved through office-based procedures with the patient under local anesthesia in the majority of patients.

Publisher

SAGE Publications

Subject

General Medicine,Otorhinolaryngology,Immunology and Allergy

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3